These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Kotsopoulos J, Lubinski J, Lynch HT, Klijn J, Ghadirian P, Neuhausen SL, Kim-Sing C, Foulkes WD, Moller P, Isaacs C, Domchek S, Randall S, Offit K, Tung N, Ainsworth P, Gershoni-Baruch R, Eisen A, Daly M, Karlan B, Saal HM, Couch F, Pasini B, Wagner T, Friedman E, Rennert G, Eng C, Weitzel J, Sun P, Narod SA, Hereditary Breast Cancer Clinical Study Group, Garber J, Osborne M, Fishman D, McLennan J, McKinnon W, Merajver S, Olsson H, Provencher D, Pasche B, Evans G, Meschino WS, Lemire E, Chudley A, Rayson D, Bellati C. Breast Cancer Res Treat; 2007 Oct; 105(2):221-8. PubMed ID: 17245541 [Abstract] [Full Text] [Related]
6. Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study. McLaughlin JR, Risch HA, Lubinski J, Moller P, Ghadirian P, Lynch H, Karlan B, Fishman D, Rosen B, Neuhausen SL, Offit K, Kauff N, Domchek S, Tung N, Friedman E, Foulkes W, Sun P, Narod SA, Hereditary Ovarian Cancer Clinical Study Group. Lancet Oncol; 2007 Jan; 8(1):26-34. PubMed ID: 17196508 [Abstract] [Full Text] [Related]
7. Risk factors for carcinoma of the fallopian tube in women with and without a germline BRCA mutation. Vicus D, Finch A, Rosen B, Fan I, Bradley L, Cass I, Sun P, Karlan B, McLaughlin J, Narod SA, Hereditary Ovarian Cancer Clinical Study Group. Gynecol Oncol; 2010 Aug 01; 118(2):155-9. PubMed ID: 20452659 [Abstract] [Full Text] [Related]
8. Parity and breast cancer risk among BRCA1 and BRCA2 mutation carriers. Antoniou AC, Shenton A, Maher ER, Watson E, Woodward E, Lalloo F, Easton DF, Evans DG. Breast Cancer Res; 2006 Aug 01; 8(6):R72. PubMed ID: 17187672 [Abstract] [Full Text] [Related]
14. Reproductive factors and breast cancer risk among BRCA1 or BRCA2 mutation carriers: results from ten studies. Pan H, He Z, Ling L, Ding Q, Chen L, Zha X, Zhou W, Liu X, Wang S. Cancer Epidemiol; 2014 Feb 01; 38(1):1-8. PubMed ID: 24332935 [Abstract] [Full Text] [Related]
16. Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations. Rennert G, Bisland-Naggan S, Barnett-Griness O, Bar-Joseph N, Zhang S, Rennert HS, Narod SA. N Engl J Med; 2007 Jul 12; 357(2):115-23. PubMed ID: 17625123 [Abstract] [Full Text] [Related]
18. Breast cancer prognosis in BRCA1 and BRCA2 mutation carriers: an International Prospective Breast Cancer Family Registry population-based cohort study. Goodwin PJ, Phillips KA, West DW, Ennis M, Hopper JL, John EM, O'Malley FP, Milne RL, Andrulis IL, Friedlander ML, Southey MC, Apicella C, Giles GG, Longacre TA. J Clin Oncol; 2012 Jan 01; 30(1):19-26. PubMed ID: 22147742 [Abstract] [Full Text] [Related]
19. Infertility, treatment of infertility, and the risk of breast cancer among women with BRCA1 and BRCA2 mutations: a case-control study. Kotsopoulos J, Librach CL, Lubinski J, Gronwald J, Kim-Sing C, Ghadirian P, Lynch HT, Moller P, Foulkes WD, Randall S, Manoukian S, Pasini B, Tung N, Ainsworth PJ, Cummings S, Sun P, Narod SA, Hereditary Breast Cancer Clinical Study Group. Cancer Causes Control; 2008 Dec 01; 19(10):1111-9. PubMed ID: 18509731 [Abstract] [Full Text] [Related]
20. Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Kotsopoulos J, Lubinski J, Lynch HT, Neuhausen SL, Ghadirian P, Isaacs C, Weber B, Kim-Sing C, Foulkes WD, Gershoni-Baruch R, Ainsworth P, Friedman E, Daly M, Garber JE, Karlan B, Olopade OI, Tung N, Saal HM, Eisen A, Osborne M, Olsson H, Gilchrist D, Sun P, Narod SA. Cancer Causes Control; 2005 Aug 01; 16(6):667-74. PubMed ID: 16049805 [Abstract] [Full Text] [Related] Page: [Next] [New Search]